Kyle McCollom
@kyle
The US gov should pay Novo $175B for the Ozempic patent (~12.5x revenue), hold it defensively, and let co’s manufacture/sell it for cheap. Would have a significant impact on annual cost of obesity ($175B) over the next decade and be a positive ROI for the US. And it’d reward Novo for its research and risk.
6 replies
2 recasts
22 reactions
Keanu Cage 🔵🎩🤘🏻
@keanucage
They certainly need to do something. As the population ages costs are only going to continue to skyrocket. Not to mention all of the COPD and lung cancer they will be hit with 20 years from now with the prevalence of vapes etc for the younger gen’s. A real healthcare spend problem and it’s honestly frightening
0 reply
0 recast
0 reaction
